Superactivation of transglutaminase type 2 without change in enzyme level occurs during progressive neurodegeneration in the mnd mouse mutant

Neurosci Lett. 1996 Aug 9;213(3):185-8. doi: 10.1016/0304-3940(96)12855-x.

Abstract

We have investigated the activity of the Ca(2+)-dependent apoptosis-related transglutaminase type 2 in the mnd/mnd mouse mutant. Transglutaminase activity in mnd/mnd central nervous system (CNS) tissue homogenates was identical to that of healthy animals at 3 months of age, but at 8 months it was greater in the mnd/mnd CNS by up to four times, depending on the region. Western blot analysis showed no difference in the level of immunoreactive transglutaminase type 2 in spinal cord homogenates between mnd/mnd and healthy mice. However, a greater number of acyl donor protein substrates of transglutaminase were identified in mnd/mnd tissue. N epsilon (gamma-Glutamyl)lysine cross-linked product of transglutaminase activity was localized to the soma of degenerating motor neurons in the mnd/mnd mouse spinal cord. We conclude that neurodegeneration in the mnd/mnd mouse is accompanied by activation of transglutaminase at substrate level. Possible mechanisms of activation and its implications for cellular pathology are discussed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Animals
  • Apoptosis / physiology
  • Blotting, Western
  • Central Nervous System / cytology
  • Central Nervous System / enzymology
  • Cross-Linking Reagents / metabolism
  • Enzyme Activation
  • Immunohistochemistry
  • Mice
  • Mice, Inbred C57BL
  • Mice, Mutant Strains
  • Motor Neurons / cytology
  • Motor Neurons / enzymology
  • Mutation / physiology
  • Nerve Degeneration / physiology*
  • Neuropeptides / analysis
  • Transglutaminases / analysis
  • Transglutaminases / immunology
  • Transglutaminases / metabolism*

Substances

  • Cross-Linking Reagents
  • Neuropeptides
  • Transglutaminases